Albiglutide is a glucagon-like peptide-1 agonist (GLP-1) biologic drug indicated in the treatment of type 2 diabetes. It is a dipeptidyl peptidase-4-resistant glucagon-like peptide-1 dimer fused to human albumin.
CAT No: 10-101-158
CAS No:782500-75-8
Synonyms/Alias:Albiglutide;782500-75-8;Eperzan;tanzeum;Albugon;Albiglutide [USAN:INN];UNII-5E7U48495E;HSDB 8282;Albiglutide pound Acetate pound(c);GSK716155;5E7U48495E;AT41897;GSK 716155;PD078276;Albugon, a recombinant human glucagon-like peptide 1-albumin protein;
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.